The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.
Open accessAbstract
Prolongation of all phospholipid-dependent coagulation tests was found in a patient with macroglobulinemia, despite absence of bleeding manifestations. The purified monoclonal IgM lambda protein and its Fabmu tryptic fragment induced similar changes in normal plasma. Patient IgM and Fabmu completely inhibited Ca++-dependent binding of radiolabeled prothrombin and Factor X to mixed phospholipid micelles. The patient's IgM lambda paraprotein reacted with phosphatidylserine and, to a lesser extent, with phosphatidylinositol and phosphatidic acid, but not with phosphatidylcholine or phosphatidylethanolamine. Prior incubation of phospholipid with patient Fabmu blocked the positive reactions. Substitution of washed platelets for phospholipid led to normalization of patient coagulation tests and corrected all abnormalities produced in normal plasma by patient IgM. Furthermore, binding of 125I-Factor Xa to thrombin-treated platelets was entirely normal in the presence of patient IgM. These studies support the concept that platelets, rather than phospholipid micelles, are the primary locus of prothrombin and Factor X activation in normal hemostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Op den Kamp, J. A. F. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.000403 · Cited by 1,261
The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.
Nesheim, M. E., Taswell, J. B., & Mann, K. G. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86616-4 · Cited by 582
Acquired inhibitors of blood coagulation.
Feinstein, D., & Rapaport, S. I. (1972) · PubMed · Cited by 521
(1963) · PubMed · Cited by 512
Immunoglobulin-producing tumors and myeloma proteins of mice.
Potter, M. (1972) · Physiological Reviews · doi:10.1152/physrev.1972.52.3.631 · Cited by 507
Thrombosis in Patients with the Lupus Anticoagulant
MUEH, J. R., HERBST, K. D., & RAPAPORT, S. I. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-2-156 · Cited by 496
Cl, C. (1952) · Journal of Clinical Investigation · Cited by 482
A Brain Extract as a Substitute for Platelet Suspensions in the Thromboplastin Generation Test
BELL, W. N., & ALTON, H. G. (1954) · Nature · doi:10.1038/174880a0 · Cited by 476
A clinical study of the lupus anticoagulant
Schleider, M., Nachman, R., Jaffe, E., & Coleman, M. (1976) · Blood · doi:10.1182/blood.v48.4.499.499 · Cited by 470
Properties of the factor Xa binding site on human platelets.
Miletich, J. P., Jackson, C. M., & Majerus, P. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38006-7 · Cited by 426
Cited by
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
Gharavi, A. E., Harris, E. N., Asherson, R. A., & Hughes, G. R. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.1.1 · Cited by 642
Lockshin, M. D., Druzin, M. L., Goei, S., Qamar, T., Magid, M. S., Jovanovic, L., & Ferenc, M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507183130304 · Cited by 583
Obstetric Complications Associated with the Lupus Anticoagulant
Branch, D. W., Scott, J. R., Kochenour, N. K., & Hershgold, E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511213132104 · Cited by 560
Carreras, L., Machin, S., Deman, R., Defreyn, G., Vermylen, J., Spitz, B., & Van Assche, A. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92087-0 · Cited by 551
Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids.
Lafer, E. M., Rauch, J., Andrzejewski, C., Mudd, D., Furie, B., Furie, B., Schwartz, R. S., & Stollar, B. D. (1981) · The Journal of experimental medicine · doi:10.1084/jem.153.4.897 · Cited by 536
Boey, M. L., Colaco, C. B., Gharavi, A. E., Elkon, K. B., Loizou, S., & Hughes, G. R. (1983) · BMJ · doi:10.1136/bmj.287.6398.1021 · Cited by 508
Oosting, J., Derksen, R., Bobbink, I., Hackeng, T., Bouma, B., & de Groot, P. (1993) · Blood · doi:10.1182/blood.v81.10.2618.2618 · Cited by 488
Immunology and clinical importance of antiphospholipid antibodies
McNeil, H. P., Chesterman, C. N., & Krilis, S. A. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60777-4 · Cited by 481
BEVERS, E. M., COMFURIUS, P., VAN RIJN, J. L. M. L., HEMKER, H. C., & ZWAAL, R. F. A. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb05898.x · Cited by 474
Harris, E. N., Gharavi, A. E., & Hughes, G. R. V. (1985) · Clinics in Rheumatic Diseases · doi:10.1016/s0307-742x(21)00606-8 · Cited by 439
The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants
Thiagarajan, P., Pengo, V, & Shapiro, S. (1986) · Blood · doi:10.1182/blood.v68.4.869.869 · Cited by 422
Self-citationFETAL SURVIVAL AFTER PREDNISONE SUPPRESSION OF MATERNAL LUPUS-ANTICOAGULANT
Lubbe, W. F., Palmer, S. J., Butler, W. S., & Liggins, G. C. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92141-4 · Cited by 422
Thiagarajan, P., & Tait, J. F. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38177-8 · Cited by 366
Self-citationHamsten, A., Björkholm, M., Norberg, R., De Faire, U., & Holm, G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92258-0 · Cited by 356
Thromboembolism in Patients With the 'Lupus'-Type Circulating Anticoagulant
Elias, M. S. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.144.3.510 · Cited by 322
Levine, S. R. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520200078024 · Cited by 301
“Lupus” Anticoagulant and Thrombosis – Possible Role of Inhibition of Prostacyclin Formation
Carreras, L. O., & Vermylen, J. G. (1982) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657211 · Cited by 295
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody
Harris, E. N., Asherson, R. A., Gharavi, A. E., Morgan, S. H., Derue, G., & Hughes, G. R. V. (1985) · British Journal of Haematology · doi:10.1111/j.1365-2141.1985.tb02988.x · Cited by 275
Anti-prothrombin antibodies and the lupus anticoagulant
Fleck, R., Rapaport, S., & Rao, L. (1988) · Blood · doi:10.1182/blood.v72.2.512.512 · Cited by 264
Viard, J.-P., Amoura, Z., & Bach, J.-F. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90049-h · Cited by 264
Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 cases
Gastineau, D. A., Kazmier, F. J., Nichols, W. L., & Bowie, E. J. W. (1985) · American Journal of Hematology · doi:10.1002/ajh.2830190308 · Cited by 257
Initiation of Coagulation by Tissue Facto
Bach, R. R. (1988) · Critical Reviews in Biochemistry · doi:10.3109/10409238809082548 · Cited by 256
The role of activated human platelets in prothrombin and factor X activation
Rosing, J., van Rijn, J., Bevers, E., van Dieijen, G., Comfurius, P., & Zwaal, R. (1985) · Blood · doi:10.1182/blood.v65.2.319.319 · Cited by 255
The Relationship Between Lupus Anticoagulants and Antibodies to Phospholipid
Triplett, D. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03720040042024 · Cited by 252
Lupus Anticoagulant Testing: Diluted Russell Viper Venom Time (dRVVT)
Pengo, V., Bison, E., Banzato, A., Zoppellaro, G., Jose, S. P., & Denas, G. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7196-1_14 · Cited by 21
Metadata
- Authors
- Thiagarajan, P., Shapiro, S. S., & De Marco, L.
- Venue
- Journal of Clinical Investigation
- Published
- 1980-09-01
- Volume
- 66
- Issue
- 3
- Pages
- 397-405
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2020307693
- Cited by
- 357
- References
- 23
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.